 | |
Displaying statins PowerPoint Presentations
Statins: Powerful Inhibitors of Cholesterol Biosynthesis PPT
Presentation Summary : Statins: Powerful Inhibitors of Cholesterol Biosynthesis Cholesterol: What is it?1 Two types of transportation for cholesterol In order to transport the steroid ...
Source : http://faculty.smu.edu/jbuynak/Statins.ppt
Presentation Summary : Statins, High-Density Lipoprotein Cholesterol, and Regression of Coronary Atherosclerosis Statins, High-Density Lipoprotein Cholesterol, and Regression of Coronary ...
Source : http://www.clinicaltrialresults.org/Slides/statins%20and%20HDL-C%20reviewed_final.ppt
Study: Statins increase life expectancy - Wayne State University PPT
Presentation Summary : Statins lowering cholesterol Cholesterol lowering drugs known as statins can increase the life expectancy of elderly patients by an average of two years, ...
Source : http://www.econ.wayne.edu/agoodman/7550/week6/Statins.ppt
Statin Talk - U S Food and Drug Administration Home Page PPT
Presentation Summary : ... Statin Pharmacodynamics & Clinical Reports All lipophilic statins were associated with reports of malformation following exposure Pravastatin, ...
Source : http://www.fda.gov/ohrms/dockets/ac/05/slides/2005-4086OPH2_04_Edison.ppt
Presentation Summary : Statins: The New Silver Bullet? Timothy Huber, MD 1st CIVDIV Oroville, CA EBM Presentation Fool or Magician? Disclaimer Off-label use talk commencing here.
Source : http://www.usafp.org/USAFP-Lectures/2006-Lectures/Sunday%2C%205%20March/Huber%20-%20Final%20Copy%20-%20Statin%20USAFP.ppt
Presentation Summary : Comparison of Intensive and Moderate Lipid Lowering with Statins after Acute Coronary Syndromes Christopher P. Cannon, M.D. et. al N Engl J Med 350; ...
Source : http://www.econ.wayne.edu/agoodman/7550/week10/Statins.ppt
Presentation Summary : Causes of death, 2001: Population: 6,122,210,000 Deaths: 56,554,000 USA 1. Infectious and parasitic diseases: 14.9 million 6. 2. Heart diseases: 11.1 million
Source : http://cmgm.stanford.edu/biochem/biochem230/papers2004/Week3/statins.ppt
JUPITER (Justification for the Use of Statins in Primary ... PPT
Presentation Summary : JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin) P Ridker (Brigham and Women's Hospital, Boston, MA)
Source : http://www.theheart.org/displayItem.do?primaryKey=1131487&type=ppt
Should statins be given to all diabetic patients ? PPT
Presentation Summary : Should statins be given to all diabetic patients ? AGAINST THE MOTION Dr Bharti Kalra Bharti Hospital Karnal Haryana NO NO NO NO Safety profile was good However ...
Source : http://www.bhartihospital.com/ppts/groupB/Should_statins_be_given_to_all_diabetic_patients.ppt
Statins in Renal Failure - CCPN - The Canadian Cardiovascular ... PPT
Presentation Summary : Statins in Renal Failure Andrea Fox Sunnybrook Health Science Center May 2010 No jokes No funny stories No time Objectives Discuss why the use of Statins in Stage 5 ...
Source : http://www.ccpn.ca/members/CCPN%20Files/Unedited%20Toronto%20Conference%202010/Statins_in_Renal_Disease_-_Andrea.ppt
Statin in Acute Coronary Syndrome - @@ Home - KKU Web Hosting PPT
Presentation Summary : There is growing interest in agents that may stabilise the plaque and discourage rupture. Statins are currently being studied in this context.
Source : http://home.kku.ac.th/mdcli/Dyslipidemia2009/Statin%20in%20Acute%20Coronary%20Syndrome.ppt
Statins in ARDS - The Scottish Intensive Care Society Audit Group PPT
Presentation Summary : Statins in ARDS Danny McAuley Queen’s University of Belfast Scottish Combined Critical Care Conference September 2010 When we analysed the 2ary outcomes, OI an ...
Source : http://www.sicsag.scot.nhs.uk/Meetings/Presentations2010/Statins_in_ARDS.ppt
Dyslipidemia: When Statins Fail - Practicing Clinicians ... PPT
Presentation Summary : 2008 Symposia Series 2 Radisson Hotel at Opryland Nashville, Tennessee May 31, 2008 * * What percentage of your patients with dyslipidemia who are receiving statin ...
Source : http://practicingclinicians.com/graphics/dyn_links/2008_tn/1--PCE_Nashville_Dyslipidemia_Lillo.ppt
Dyslipidemia: When Statins Fail - Practicing Clinicians ... PPT
Presentation Summary : 2008 Symposia Series 1 Hilton Irvine/Orange County Airport Irvine, California March 29, 2008 * * What percentage of your patients with dyslipidemia who are receiving ...
Source : http://practicingclinicians.com/graphics/dyn_links/2008_series1/1-PCE_Irvine_Dyslipidemia_Robitshek.ppt
Pro ED Suggested Revisions to Crestor™ Slide Style Guide PPT
Presentation Summary : ... safety profile similar to marketed statins Greater lipid modification achieved with rosuvastatin Increased frequency of adverse effects at the 80-mg dose 2% ...
Source : http://www.fda.gov/ohrms/dockets/ac/03/slides/3968S1_01_C-AstraZeneca-Safety.ppt
Presentation Summary : Blinded Patients had no previous history of statin treatment or atrial fibrillation Mechanisms by Which Statins Reduce Reperfusion Injury Reduce monocyte CD11b ...
Source : http://clintrialresults.org/Slides/Gibson%20-%20pre%20pci%20statin%20therapy%20short.ppt
Presentation Summary : ... more and more patients discontinue their statins with each passing month: Roughly one-quarter stop at the end of their first prescription, ...
Source : http://www.statinusage.com/Documents/usage-presentation.ppt
Effects of the CETP Inhibitor Evacetrapib Administered as ... PPT
Presentation Summary : Effects of the CETP Inhibitor Evacetrapib Administered as Monotherapy or in Combination With Statins on HDL and LDL Cholesterolby: Nicholls, Stephen J. MBBS, PHD ...
Source : http://www.segageriatrics.com/wp/wp-content/uploads/2011/12/Effects-of-the-CETP-Inhibitor-Evacetrapib-Administered-as.pptx
Rhabdomyolysis and lipid-lowering agent induced myopathy PPT
Presentation Summary : No increase from fenofibrate i.e. Fenofibrate preferred if also on statin CoQ10 Decreased synthesis when on statins May increase muscle destruction due to ...
Source : http://www.med.unc.edu/medicine/web/10.22.07%20Rhabdomyolysis%20Rometo.ppt
Lipids and Diabetes - The Official Home Page of the United ... PPT
Presentation Summary : ... Myopathy Monitor LFTs Statins and Myopathy Prevention – Assess risk factors Elderly (especially > 80) Women > men Renal dysfunction Drug interactions ...
Source : https://www.qmo.amedd.army.mil/diabetes/Educator_Conf_07/Lipids_in_Diabetes.ppt
Presentation Summary : As with other statins, the risk of myopathy during treatment with rosuvastatin may be increased with concurrent administration of other lipid-lowering therapies, ...
Source : http://www.diegori.it/InternetMedico/ArticoliMedici/LineeGuida%2CStudiCliniciControllati/STELLAR%20Study%20(Rosuvastatina).ppt
Antihyperlipidemic Agents - www.people.vcu.edu PPT
Presentation Summary : Statins Fibrates Bile Acid Sequestrants Nicotinic Acid Ezetimibe Biosynthesis of Cholesterol CH3-C-SCoA -OOC-CH2-C-CH2-C- SCoA O ...
Source : http://www.people.vcu.edu/~urdesai/Lectures/MEDC603/AntihyperlipidemicAgents_Fall2007.ppt
